Most of 23andMe bought for a lot more than one could have thought–and why? Yesterday, the board of 23andMe confirmed that they have a court-approved definitive agreement for the sale of their core ...

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...

The once-popular genetic testing company will be acquired by Regeneron after filing for bankruptcy, but the questions about ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

Regeneron to acquire nearly all of 23andMe’s assets for $256M, marking a new chapter for the direct-to-consumer genetic testing pioneer.

OKLAHOMA CITY (KFOR) – The Oklahoma Attorney General’s Office is offering tips to Oklahoma consumers in wake of the 23andMe bankruptcy filed last month. According to A.G. Gentner Drummond’s ...

More than a dozen states, including Virginia, have passed some version of a genetic information privacy law since 2020 ...

(Bloomberg) -- Multiple bidders are likely to submit offers for the DNA data bank and other assets of bankrupt genetic-testing firm 23andMe, according to a lawyer for the company. Although 23andMe ...

SAN FRANCISCO (KRON) — 23andMe is closing its San Francisco office and possibly cutting 250 jobs. The latest moves come after the personal genomics company filed for Chapter 11 bankruptcy ...